- NLM Digital Collections - The Surgeon General's Workshop on Increasing Organ Donation: Proceedings (pages 1-25)Publication: United States. Public Health Service. Office of the Surgeon General, 1991... transplantation, predominant problems are: acute and chronic rejection, graft vs. host disease, diagnosis of rejection, and the digestive and non-digestive ...
- NLM Digital Collections - The Surgeon General's Workshop on Increasing Organ Donation: ProceedingsPublication: United States. Public Health Service. Office of the Surgeon General, 1991... transplantation, predominant problems are: acute and chronic rejection, graft vs. host disease, diagnosis of rejection, and the digestive and non-digestive ...
- NLM Digital Collections - Chimeric antigen receptor T-cell therapy for B-cell cancers : effectiveness and value : final ...Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, March 23, 2018... ALL Systemic infection None Age < 21 years at diagnosis Symptomatic CNS Refractory or in second or subsequent relapse disease ≥ 25% blasts in bone marrow Active graft versus Performance status ≥50% host disease SCT in past 3 months Hijiya 201122 ...
- NLM Digital Collections - AIDS bibliography, 1986-1987Publication: [Bethesda, Md.] : Reference Section, Public Services Division, National Library of Medicine, U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, 1987... Bone Marrow- TRANSPLANTATION/ Cell Differentiation/ Child, Preschool/ Female/ Graft vs ... Adult/ Candidiasis, Oral- DIAGNOSIS- ETIOLOGY/ Carcinoma, Squamous ...
- ... and the risk of related-donor transfusion-associated graft-versus-host disease. McMilin KD, et al. Transfus Med Rev 1993 ... and the risk of related-donor transfusion-associated graft-versus-host disease. McMilin KD, et al. Transfus Med Rev 1993 ...
- ... of the cases in the 483 ELIMINATION OF GRAFT-VERSUS-HOST DISEASE BY IN-VITRO DEPLETION OF ALLOREACTIVE LYMPHOCYTES WITH ... T-cell antibody (0-0-5%). No anti-graft-versus-host disease prophylaxis was given after transplantation. Rapid engraftment was ...
- NLM Digital Collections - Gene therapies for sickle cell disease : final evidence reportPublication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, August 21, 2023... Drug Administration g/dL gram per deciliter GVHD Graft-versus-host disease HLA Human leukocyte antigen HSCT Hematopoietic stem cell ... HSCT has a risk of graft failure/rejection, graft-versus-host disease (GVHD), acute complications during the transplant process, and ...
- NLM Digital Collections - Betibeglogene autotemcel for beta thalassemia : effectiveness and value : final evidence ...Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, July 19, 2022... cel, HSCT places the recipient at risk for graft versus host disease. As we heard from patients living with TDT ... that it does not impose a risk of graft-versus-host disease or rejection. Despite these risks, advances in HSCT ...
- ... marrow transplantation: effect on infectious complications, fever and graft versus host disease. Skinh0j P, et al. Scand J Infect Dis ... marrow transplantation: effect on infectious complications, fever and graft versus host disease. Skinh0j P, et al. Scand J Infect Dis ...
- NLM Digital Collections - Analysis of supply, distribution, demand, and access issues associated with immune globulin ...Publication: Washington, D.C. : U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, 2007... pneumonia of infectious or idiopathic causes, and acute graft-versus-host disease after transplantation Source: Orange et al., 2006 An ... reduce the incidences of infection and to prevent graft versus host disease, in which the new donor cells attack the ...
290 results